Agency Forms Undergoing Paperwork Reduction Act Review, 62852-62853 [2022-22506]
Download as PDF
<![CDATA[
62852
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–22454 Filed 10–14–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–1154]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Generic
Clearance for CDC/ATSDR Formative
Research and Tool Development’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on July 22, 2022 to obtain
comments from the public and affected
agencies. CDC did not receive comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
VerDate Sep<11>2014
17:35 Oct 14, 2022
Jkt 259001
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Generic Clearance for CDC/ATSDR
Formative Research and Tool
Development (OMB Control No. 0920–
1154, Exp. 1/31/2023)—Extension—
Office of Scientific Integrity (OSI),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) requests approval for
an Extension of a Generic Clearance for
CDC/ATSDR Formative Research and
Tool Development. This information
collection request is designed to allow
CDC to conduct formative research
information collection activities used to
inform many aspects of surveillance,
communications, health promotion, and
research project development at CDC.
Formative research is the basis for
developing effective strategies including
communication channels, for
influencing behavior change. It helps
researchers identify and understand the
characteristics—interests, behaviors and
needs—of target populations that
influence their decisions and actions.
Formative research is integral in
developing programs as well as
improving existing and ongoing
programs. Formative research looks at
the community in which a public health
intervention is being or will be
implemented and helps the project staff
understand the interests, attributes and
needs of different populations and
persons in that community. Formative
research occurs before a program is
designed and implemented, or while a
program is being conducted.
At CDC, formative research is
necessary for developing new programs
or adapting programs that deal with the
complexity of behaviors, social context,
cultural identities, and health care that
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
underlie the epidemiology of diseases
and conditions in the U.S. CDC
conducts formative research to develop
public-sensitive communication
messages and user-friendly tools prior to
developing or recommending
interventions, or care. Sometimes these
studies are entirely behavioral but most
often they are cycles of interviews and
focus groups designed to inform the
development of a product.
Products from these formative
research studies will be used for
prevention of disease. Findings from
these studies may also be presented as
evidence to disease-specific National
Advisory Committees, to support
revisions to recommended prevention
and intervention methods, as well as
new recommendations.
Much of CDC’s health communication
takes place within campaigns that have
fairly lengthy planning periods—
timeframes that accommodate the
standard federal process for approving
data collections. Short term qualitative
interviewing and cognitive research
techniques have previously proven
invaluable in the development of
scientifically valid and populationappropriate methods, interventions, and
instruments.
This request includes studies
investigating the utility and
acceptability of proposed sampling and
recruitment methods, intervention
contents and delivery, questionnaire
domains, individual questions, and
interactions with project staff or
electronic data collection equipment.
These activities will also provide
information about how respondents
answer questions and ways in which
question response bias and error can be
reduced.
This request also includes collection
of information from public health
programs to assess needs related to
initiation of a new program activity or
expansion or changes in scope or
implementation of existing program
activities to adapt them to current
needs. The information collected will be
used to advise programs and provide
capacity-building assistance tailored to
identify needs.
Overall, these development activities
are intended to provide information that
will increase the success of the
surveillance or research projects
through increasing response rates and
decreasing response error, thereby
decreasing future data collection burden
to the public. The studies that will be
covered under this request will include
one or more of the following
investigational modalities: (1) structured
and qualitative interviewing for
surveillance, research, interventions and
E:\FR\FM\17OCN1.SGM
17OCN1
62853
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
material development; (2) cognitive
interviewing for development of specific
data collection instruments; (3)
methodological research; (4) usability
testing of technology-based instruments
and materials; (5) field testing of new
methodologies and materials; (6)
investigation of mental models for
health decision-making, to inform
health communication messages; and (7)
organizational needs assessments to
support development of capacity.
Respondents who will participate in
individual and group interviews
(qualitative, cognitive, and computer
assisted development activities) are
selected purposively from those who
respond to recruitment advertisements.
In addition to utilizing advertisements
for recruitment, respondents who will
participate in research on survey
methods may be selected purposively or
systematically from within an ongoing
surveillance or research project.
Participation of respondents is
voluntary. There is no cost to
participants other than their time. The
total estimated annual burden requested
is 20,000 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
General public and health care providers ......
Screener .........................................................
Interview .........................................................
Focus group interview ....................................
Survey ............................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–22506 Filed 10–14–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–0976]
Agency Forms Undergoing Paperwork
Reduction Act Review
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Million Hearts
Hypertension Control Champions
Challenge’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on December
21, 2021 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
VerDate Sep<11>2014
17:35 Oct 14, 2022
Jkt 259001
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Million Hearts Hypertension Control
Champions Challenge (OMB Control No.
0929–0976, Exp. 11/30/2022)—
Extension—National Center for Chronic
Disease Prevention and Health
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
10,000
5,000
5,000
5,000
Number of
responses per
respondent
1
1
1
1
Average
hours per
response
15/60
1
2
30/60
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Cardiovascular disease is a leading
cause of death for men and women in
the United States, among the most
costly health problems facing our nation
today, and among the most preventable.
Heart disease and stroke also contribute
significantly to disability. High blood
pressure, also known as hypertension, is
one of the leading causes of heart
disease and stroke. Currently, about 78
million American adults have high
blood pressure but only about half
(48%) have adequately controlled blood
pressure. The costs of hypertension are
estimated at $48.9 billion annually in
direct medical costs.
In September 2011, CDC launched the
Million Hearts initiative to prevent one
million heart attacks and strokes by
2017. In February 2022, CDC launched
Million Hearts 2027 to continue to
prevent one million heart attacks,
strokes, and related health conditions.
In order to achieve this goal, at least 10
million more Americans must have their
blood pressure under control. Million
Hearts is working to reach this goal
through the promotion of clinical
practices that are effective in increasing
blood pressure control among patient
populations. There is scientific evidence
that provides general guidance on the
types of system-based changes to
clinical practice that can improve
patient blood pressure control, but
additional information is needed to
fully understand implementation
practices so that they can be shared and
promoted.
In 2013, CDC launched the Million
Hearts Hypertension Control Challenge,
authorized by Public Law 111–358, the
America Creating Opportunities to
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Pages 62852-62853]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22506]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-1154]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Generic Clearance for CDC/ATSDR Formative
Research and Tool Development'' to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on July 22, 2022 to obtain comments from the public and affected
agencies. CDC did not receive comment related to the previous notice.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Generic Clearance for CDC/ATSDR Formative Research and Tool
Development (OMB Control No. 0920-1154, Exp. 1/31/2023)--Extension--
Office of Scientific Integrity (OSI), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) requests
approval for an Extension of a Generic Clearance for CDC/ATSDR
Formative Research and Tool Development. This information collection
request is designed to allow CDC to conduct formative research
information collection activities used to inform many aspects of
surveillance, communications, health promotion, and research project
development at CDC. Formative research is the basis for developing
effective strategies including communication channels, for influencing
behavior change. It helps researchers identify and understand the
characteristics--interests, behaviors and needs--of target populations
that influence their decisions and actions.
Formative research is integral in developing programs as well as
improving existing and ongoing programs. Formative research looks at
the community in which a public health intervention is being or will be
implemented and helps the project staff understand the interests,
attributes and needs of different populations and persons in that
community. Formative research occurs before a program is designed and
implemented, or while a program is being conducted.
At CDC, formative research is necessary for developing new programs
or adapting programs that deal with the complexity of behaviors, social
context, cultural identities, and health care that underlie the
epidemiology of diseases and conditions in the U.S. CDC conducts
formative research to develop public-sensitive communication messages
and user-friendly tools prior to developing or recommending
interventions, or care. Sometimes these studies are entirely behavioral
but most often they are cycles of interviews and focus groups designed
to inform the development of a product.
Products from these formative research studies will be used for
prevention of disease. Findings from these studies may also be
presented as evidence to disease-specific National Advisory Committees,
to support revisions to recommended prevention and intervention
methods, as well as new recommendations.
Much of CDC's health communication takes place within campaigns
that have fairly lengthy planning periods--timeframes that accommodate
the standard federal process for approving data collections. Short term
qualitative interviewing and cognitive research techniques have
previously proven invaluable in the development of scientifically valid
and population-appropriate methods, interventions, and instruments.
This request includes studies investigating the utility and
acceptability of proposed sampling and recruitment methods,
intervention contents and delivery, questionnaire domains, individual
questions, and interactions with project staff or electronic data
collection equipment. These activities will also provide information
about how respondents answer questions and ways in which question
response bias and error can be reduced.
This request also includes collection of information from public
health programs to assess needs related to initiation of a new program
activity or expansion or changes in scope or implementation of existing
program activities to adapt them to current needs. The information
collected will be used to advise programs and provide capacity-building
assistance tailored to identify needs.
Overall, these development activities are intended to provide
information that will increase the success of the surveillance or
research projects through increasing response rates and decreasing
response error, thereby decreasing future data collection burden to the
public. The studies that will be covered under this request will
include one or more of the following investigational modalities: (1)
structured and qualitative interviewing for surveillance, research,
interventions and
[[Page 62853]]
material development; (2) cognitive interviewing for development of
specific data collection instruments; (3) methodological research; (4)
usability testing of technology-based instruments and materials; (5)
field testing of new methodologies and materials; (6) investigation of
mental models for health decision-making, to inform health
communication messages; and (7) organizational needs assessments to
support development of capacity. Respondents who will participate in
individual and group interviews (qualitative, cognitive, and computer
assisted development activities) are selected purposively from those
who respond to recruitment advertisements. In addition to utilizing
advertisements for recruitment, respondents who will participate in
research on survey methods may be selected purposively or
systematically from within an ongoing surveillance or research project.
Participation of respondents is voluntary. There is no cost to
participants other than their time. The total estimated annual burden
requested is 20,000 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Form name Number of responses per Average hours
respondents respondent per response
----------------------------------------------------------------------------------------------------------------
General public and health care Screener................ 10,000 1 15/60
providers. Interview............... 5,000 1 1
Focus group interview... 5,000 1 2
Survey.................. 5,000 1 30/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-22506 Filed 10-14-22; 8:45 am]
BILLING CODE 4163-18-P
